QCG
MRVI icon

Quadrant Capital Group’s Maravai LifeSciences MRVI Stock Holding History

Quadrant Capital Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,075
Closed -$31.3K – 2062
2026
Q1 		$31.3K Hold
11,075
– – ﹤0.01% 1855
2025
Q4 		$36K Hold
11,075
– – ﹤0.01% 1794
2025
Q3 		$31.8K Buy
+11,075
New +$28.3K ﹤0.01% 1810
2025
Q2 		– Sell
-5,940
Closed -$13.1K – 2114
2025
Q1 		$13.1K Buy
5,940
+4,263
+254% +$16.8K ﹤0.01% 2152
2024
Q4 		$9.14K Sell
1,677
-1,940
-54% -$12.5K ﹤0.01% 2151
2024
Q3 		$30.1K Sell
3,617
-1,114
-24% -$9.63K ﹤0.01% 1723
2024
Q2 		$33.9K Sell
4,731
-204
-4% -$1.76K ﹤0.01% 1607
2024
Q1 		$42.8K Buy
4,935
+1,666
+51% +$11.3K ﹤0.01% 1483
2023
Q4 		$21.4K Buy
3,269
+3
+0.1% +$19 ﹤0.01% 1789
2023
Q3 		$32.7K Buy
3,266
+2,511
+333% +$27.6K ﹤0.01% 1472
2023
Q2 		$9.38K Sell
755
-1,578
-68% -$21.3K ﹤0.01% 2016
2023
Q1 		$32.7K Buy
2,333
+1,688
+262% +$24.2K ﹤0.01% 1456
2022
Q4 		$9.23K Buy
645
+429
+199% +$6.75K ﹤0.01% 1987
2022
Q3 		$6K Buy
+216
New +$5.42K ﹤0.01% 2079
2022
Q1 		– Sell
-4
Closed – – 2621
2021
Q4 		$0 Hold
4
– – ﹤0.01% 2631
2021
Q3 		$0 Buy
+4
New +$195 ﹤0.01% 2594

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Quadrant Capital Group's MRVI Position: Q2 2026 in Review

Quadrant Capital Group sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 11,075 shares — an estimated $31.3K sold.

Quadrant Capital Group first reported a position in MRVI in Q3 2021 and held it in 16 quarters. The position peaked at $42.8K in Q1 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Quadrant Capital Group reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 11,075 Maravai LifeSciences shares in Q2 2026, an estimated $31.3K.
  • Quadrant Capital Group first reported a position in Maravai LifeSciences in Q3 2021 and held it in 16 quarters.
  • Quadrant Capital Group's Maravai LifeSciences position peaked at $42.8K in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.